Notarangelo, S.; Lombardi, R.; Lombardi, M.; Liguori, G.; Taurchini, M.; Sperandeo, M.; Specchiulli, L.; Conte, P.; Checola, F.; Langella, E.;
et al. The New Frontier in Small-Cell Lung Cancer: Can Atezolizumab Ensure Enduring Stability? Sci. Pharm. 2025, 93, 29.
https://doi.org/10.3390/scipharm93030029
AMA Style
Notarangelo S, Lombardi R, Lombardi M, Liguori G, Taurchini M, Sperandeo M, Specchiulli L, Conte P, Checola F, Langella E,
et al. The New Frontier in Small-Cell Lung Cancer: Can Atezolizumab Ensure Enduring Stability? Scientia Pharmaceutica. 2025; 93(3):29.
https://doi.org/10.3390/scipharm93030029
Chicago/Turabian Style
Notarangelo, Stefano, Renato Lombardi, Massimo Lombardi, Giovanna Liguori, Marco Taurchini, Marco Sperandeo, Leonardo Specchiulli, Paola Conte, Fabrizia Checola, Emilia Langella,
and et al. 2025. "The New Frontier in Small-Cell Lung Cancer: Can Atezolizumab Ensure Enduring Stability?" Scientia Pharmaceutica 93, no. 3: 29.
https://doi.org/10.3390/scipharm93030029
APA Style
Notarangelo, S., Lombardi, R., Lombardi, M., Liguori, G., Taurchini, M., Sperandeo, M., Specchiulli, L., Conte, P., Checola, F., Langella, E., Giordano, A., Bava, R., & Ruga, S.
(2025). The New Frontier in Small-Cell Lung Cancer: Can Atezolizumab Ensure Enduring Stability? Scientia Pharmaceutica, 93(3), 29.
https://doi.org/10.3390/scipharm93030029
